Massmed Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 389.98%
- Profit Growth 1681.52%
- Ebitda 1488.08%
- Net Worth 91.93%
- Total Assets 56.53%
About Massmed
Massmed Private Limited (MPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 May 2018 (Six years and eight months 6 days old ). Its registered office is in Ahmedabad, Gujarat.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
LocationAhmedabad, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51900GJ2018PTC102571
-
Company No.
102571
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 May 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Massmed?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Borad
|
Director | 29-May-2018 | Current |
|
Mihir Shah
|
Director | 29-May-2018 | Current |
|
Sanjay Singh
|
Director | 29-May-2018 | Current |
|
Sandeep Ranjan
|
Director | 29-May-2018 | Current |
Financial Performance of Massmed.
Massmed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 389.98% increase. The company also saw a substantial improvement in profitability, with a 1681.52% increase in profit. The company's net worth Soared by an impressive increase of 91.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Massmed?
In 2023, Massmed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Oneextramiles Tours Private LimitedSanjay Singh is a mutual person
-
Red Marketing Services Private Limited
Sanjay Singh is a mutual person
-
Neonectar Private Limited
Sanjay Singh is a mutual person
-
Vitam Healthcare Private Limited
Sanjay Singh and Sandeep Ranjan are mutual person
-
Ilan Pharma Private Limited
Anurag Borad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Massmed?
Unlock and access historical data on people associated with Massmed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Massmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Massmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.